Elabela-APJ axis: a novel therapy target for cardiovascular diseases.

Li, Lanfang; Zhou, Qionglin; Li, Xiaoxiao; Chen, Linxi

Li, Lanfang; Zhou, Qionglin; Li, Xiaoxiao; Chen, Linxi.

Affiliation

Li L; Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China.
Zhou Q; Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China.
Li X; Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China.
Chen L; Institute of Pharmacy and Pharmacology, Learning Key Laboratory for Pharmacoproteomics, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China.

Acta Biochim Biophys Sin (Shanghai) ; 49(11): 1042-1043, 2017 11 01.

Article in En | MEDLINE | ID: mdl-29036564

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Signal Transduction / Peptide Hormones / Apelin Receptors Limits: Animals / Humans Language: En Journal: Acta Biochim Biophys Sin (Shanghai) Journal subject: BIOFISICA / BIOQUIMICA Year: 2017 Document type: Article Affiliation country: China Country of publication: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google